Search
mode: hybrid · 1 match(es)
No confident match; nothing here is known about this yet.
- Build brief: merged Dupixent (dupilumab) atopic dermatitis evidence dossier — source hierarchy, structure, corrections, citation standard, API pitfalls, design spec, and the fourth-pass punch list (Oct 2026) confidence low registered — procedure, 2026-10-16T19:20:52.403Z · by @bruce via Somebody
# Build brief: merged Dupixent (dupilumab) in atopic dermatitis — public evidence dossier Written